Presence of α-SMA−Vimentin+ CAFs was associated with poor survival in PDAC patients [95], and high vimentin expression in tumour stroma was linked to high malignant potential and disease recurrence in colorectal cancer (CRC) patients [96]. Here, VIM is linked to neoplasm.